TOME BIOSCIENCES
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
TOME BIOSCIENCES
Social Links:
Industry:
Biotechnology Genetics Medical
Founded:
2021-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.tome.bio
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Official Site Inspections
http://www.tome.bio
- Host name: 166.117.68.124
- IP address: 166.117.68.124
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tome Biosciences"
Tome Biosciences: What Went Wrong and How to …
Aug 26, 2024 Here, we'll get into - Tome Biosciences: What Went Wrong and How to Avoid Their Fate. Our blog covers a wide range of topics in the life sciences including data science, engineering, and biology, as well as …See details»
tome.bio
Tome Biosciences specializes in programmable genomic integration technologies to develop innovative treatments for various diseases.See details»
Tome Biosciences - Crunchbase Company Profile
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any …See details»
Tome Biosciences debuts with $213M and a new way …
Dec 12, 2023 Biotechnology startup Tome Biosciences emerged from stealth on Tuesday with $213 million in venture funding to develop a new gene editing …See details»
Tome Biosciences Launches with Over $200 Million in Funding
Dec 12, 2023 Release Summary Tome Biosciences launches with over $200 million in funding to advance programmable genomic integration (PGI).See details»
Tome Biosciences, once a high-flying gene-editing …
Aug 22, 2024 Exclusive: Buzzy gene-editing startup Tome Biosciences is floundering, just nine months after launching with $213 million in funding.See details»
Tome Biosciences, Inc. - life-sciences-usa.com
Dec 12, 2023 Tome Biosciences, Inc., is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the …See details»
Tome Bio founders wrangle jumping genes to create new ... - talk.bio
Apr 11, 2025 Tome Bio developed Programmable Gene Insertion (PGI), a revolutionary gene-editing tool inspired by retrotransposons (jumping genes). PGI enables precise insertion of …See details»
Company: Tome Bioscience Inc. - CRISPR Medicine
Tome Biosciences, Inc. is the developer of the programmable genomic integration (PGI) technology that allows for site-specific insertion of genetic sequences of any size into the …See details»
Tome Biosciences - Company info. interviews, news
Jan 12, 2024 Tome Biosciences is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome …See details»
Gene Editing Startup Tome Struggles to Stay Afloat Just
Aug 23, 2024 Tome Biosciences, which launched with a mission to revolutionize genomic medicines, has pared down operations and is exploring its “strategic options” due to a shift in …See details»
Tome Biosciences - News, Layoffs, Locations and Executives
Usearch identified 2 signals for Tome Biosciences, including: 1 Startup Funding and 1 Layoffs. Usearch has identified 2 executives & key decision-makers.See details»
Tome Biosciences Launches with Over $200 Million in Funding to …
WATERTOWN, Mass., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Tome Biosciences, Inc., the programmable genomic integration company, has launched to usher in a new era of genomic …See details»
Longwood Fund - Tome Bio
Tome Biosciences, Inc., is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome …See details»
Tome Biosciences - Funding, Financials, Valuation & Investors
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.See details»
Gene insertion startup Tome Biosciences stops lab work as CEO ...
Aug 23, 2024 Tome Biosciences, a high-profile gene editing startup spun out of MIT, is halting its lab work and looking to sell itself or find a partner to continue developing its technology ...See details»
Tome Biosciences – The programmable genomic integration …
Join Tome Biosciences to work on cutting-edge genomic integration technologies and help deliver cures for various diseases.See details»
Tome Biosciences Halts Operations Amid Financial Strains
Aug 23, 2024 Layoffs and Operations Halt: Tome Biosciences, a gene editing startup, is laying off nearly its entire staff of 131 employees by November due to financial difficulties. Financial …See details»
Tome Biosciences Launches with Over $200 Million in Funding
Dec 12, 2023 Tome Biosciences, Inc., the programmable genomic integration company, has launched to usher in a new era of genomic medicines based on programmable genomic …See details»
Tome Bio founders wrangle ‘jumping genes’ for new gene …
Apr 11, 2025 Tome Bio founders wrangle ‘jumping genes’ to create new programmable gene insertion tool Ryan Cross Senior Science CorrespondentSee details»